MGSSHHHHHH SSGLVPRGSH MEAQAQGLLE TEPLQGTDED AVASADFSSM LSEEEKEELK AELVQLEDEI TTLRQVLSAK ERHLVEIKQK LGMNLMNELK QNFSKSWHDM QTTTAYKKTH ETLSHAGQKA TAAFSNVGTA ISKKFGDMRR K.
The TPD52 family was initially identified through studies focused on cancer cells, where these proteins were found to be overexpressed. TPD52L1, in particular, has been studied for its involvement in various types of cancers, including breast, prostate, and ovarian cancers. The protein is composed of approximately 180 amino acids and has a molecular weight of around 28 kDa .
TPD52L1 is involved in several cellular functions:
Recombinant Human Tumor Protein D52 L1 is produced using recombinant DNA technology. This involves inserting the gene encoding TPD52L1 into an expression system, such as bacteria or yeast, to produce the protein in large quantities. The recombinant protein is then purified for use in research and therapeutic applications .
The recombinant form of TPD52L1 is widely used in scientific research to study its role in cancer and other diseases. It is also utilized in drug development to identify potential therapeutic targets. Additionally, TPD52L1 can be used in diagnostic assays to detect its expression levels in various cancer types .